Multi-Tissue Organoid Better Predicts Human Response to Drug Treatments: CellCipher

CellCipher has developed a new type of organoid model that captures nearly 70 different cell types to enable drug discovery and personalized medicine. In vitro human models, including organoids…

Two UChicago Startups Receive Investment from the George Shultz Innovation Fund

The George Shultz Innovation Fund (fall 2023 cycle) has awarded $200,000 to NetMicroscope and $150,000 to CellCipher to further develop their work. Managed by the Polsky Center for Entrepreneurship and…

Life Sciences, Tech Startups Advance to Fall 2023 George Shultz Innovation Fund Finals

Researchers have developed a proprietary machine learning approach, multi-tissue human organoid model, and a targeted drug delivery method – and will be seeking investment at the fall 2023 George Shultz…

10 Teams Participate in Polsky’s Spring 2022 I-Corps Program to Refine Market Fit for Novel Tech

Ten teams from across the University of Chicago were selected to participate in the spring 2022 I-Corps program with the goal of determining the commercial potential of their technologies. Supported…

Winter Collaboratorium to Feature Research from Across the Data Science Institute, Biological Sciences Division, and Pritzker School of Molecular Engineering

The Collaboratorium unites University of Chicago students with researchers and faculty who are exploring commercialization opportunities for their work. The program provides the opportunity for scientists and researchers who want…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept